Immunovaccine and Leidos are working together to determine the most promising malaria vaccine formulations.

Now that Prostvac has failed as a stand-alone therapy, Bavarian Nordic's MVA-BN RSV vaccine is now extra-important.

Here is some other vaccine news of note for the week.

Takeda's dengue vaccine induced sustained antibody responses in children, topline phase 2 data showed.

Here is some other vaccine news of note for this week.

China's FDA approved a domestically developed Ebola vaccine based on a different virus type from GSK's and Merck's shots.

No currently available vaccines against typhoid are meant for children younger than 2, but a new WHO endorsement could change that.

Young biotech Codagenix just secured $3 million in funding to advance its live-attenuated RSV vaccine candidate.

A large-scale phase 3 study shows that Merck's Gardasil 9 vaccine protects against HPV-related cancers for at least six years.